VisageX Medical

Non-invasive post-surgical Adjustable Facial Implants for Reconstructive and Aesthetics Surgery

Health Tech & Life Sciences
Stealth Mode

Company Overview

Snapshot

Founded in March 2022 by Gideon Meyer Brodnitz, VisageX Medical operates with 1–10 employees. The company has raised $1.45M across four funding rounds. In July 2024, VisageX Medical secured a grant.

Business overview

VisageX Medical is pioneering a new category of medical implants with its Adjustable Permanent Implants (API) technology. These smart, programmable implants can be reshaped non-invasively after implantation using induction heating of shape memory materials. The company's initial focus is on facial reconstructive implants for craniomaxillofacial (CMF) surgery, addressing the limitations of static implants and the frequency of revisions. VisageX Medical aims to expand this platform to various clinical applications, including aesthetic, cranial, orthopedic, urological, and ENT indications, serving both B2B and B2C markets globally.

Company Intelligence Q&A

What is VisageX Medical's core technology?
VisageX Medical develops Adjustable Permanent Implants (API), which are smart, programmable implants that can be reshaped non-invasively after implantation using induction heating of shape memory materials.
When was VisageX Medical founded?
VisageX Medical was founded in March 2022.
Who is the founder of VisageX Medical?
Gideon Meyer Brodnitz is the Co-founder & CEO of VisageX Medical.
What is the primary application of VisageX Medical's technology?
VisageX Medical's technology is initially focused on non-invasive post-surgical adjustable facial implants for reconstructive and aesthetic surgery, particularly in craniomaxillofacial (CMF) surgery.
What is the total capital raised by VisageX Medical?
VisageX Medical has raised a total of $1.45M across four funding rounds.

External links